Safety, Tolerability and PK of Intravenous (IV) ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunteers
Clinical trial NCT01952444 · COMPLETED
Trial details
- NCT number
- NCT01952444
- Sponsor
- Elusys Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-29
- Primary completion
- 2014-04-09
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.